Police arrest pharmacist over unprofessional treatment of patient in Bauchi
The Police have arrested a pharmaceutical shop owner over unprofessional negligence and degrading treatment meted on a patient in Bauchi state.
As contained in a crime bulletin made available to newsmen by the Police Public Relations Officer (PPRO), CSP Ahmed Mohammad Wakil on Friday, the arrest was in response to a letter of complaint from the Ministry of Humanitarian Affairs and Disaster Management against Ibrahim, the CEO of Hamdala Special Medicine Store, located in Yelwa area of Bauchi metropolis.
According to CSP Wakil, the petition indicated that “our office received a complaint against Ibrahim AKA degree, who operates a Pharmaceutical store situated at Yalwa area, Bauchi”.
He said a 15-year-old female patient, Maryam Magaji, residing in Yelwa Lebura, Bauchi, who experienced health issues was taken to the medicine store for medical treatment and was administered an injection for malaria, which subsequently led to significant bodily harm.
The PPRO disclosed that the victim was later evacuated to a hospital, where medical professionals confirmed that her injuries were a direct consequence of the administered injection.
CSP Wakil stated that upon receipt of the petition, the Command responded promptly by arresting the suspect.
He said during interrogation process, the individual was identified as Ibrahim Hassan Mamman, a 27-year-old resident of Isa Yuguda Guest House in Bauchi, who voluntarily confessed to the allegations against him.
CSP Wakil said preliminary investigations revealed that the suspect lacks the necessary qualifications to practice as a healthcare professional, specifically not being a doctor or a licensed pharmacist.
He said additional investigations revealed that the suspect willfully injected the victim despite his lack of knowledge in diagnosing health issues or administering injections.
The PPRO also noted that subsequent search of the suspect’s pharmacy uncovered expired medications, including Children’s Tuxil, manufactured by Fidson Healthcare Plc, which expired in August 2024; Tuxil suspension, manufactured by Tuyil Pharmaceuticals Ltd., expiring on May 17, 2025; and various other medications set to expire within the month.
